Insights into the molecular basis of the nod2 signalling pathway

Open Biology

Volumn 4, Issue 12, 2014, Pages

  Boyle, Joseph P ^a   Parkhouse, Rhiannon ^a   Monie, Tom P ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

Author keywords

Innate immunity; NLR; NOD1 2; Post translational modification; RIP2 kinase; Signal transduction

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; NOD1 PROTEIN, HUMAN; NOD2 PROTEIN, HUMAN;

ANIMAL; ARTHRITIS; AUTOPHAGY; CHEMISTRY; CRANIAL NEUROPATHY; CROHN DISEASE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE; METABOLISM; MICROBIOLOGY; SIGNAL TRANSDUCTION; SYNOVITIS; UVEITIS;

ANIMALS; ARTHRITIS; AUTOPHAGY; CRANIAL NERVE DISEASES; CROHN DISEASE; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTESTINES; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; SIGNAL TRANSDUCTION; SYNOVITIS; UVEITIS;

EID: 84923544204     PISSN: None     EISSN: 20462441     Source Type: Journal    
DOI: 10.1098/rsob.140178     Document Type: Article

References (108)

1. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. 2001 Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kB. J. Biol. Chem. 276, 4812-4818. (doi:10.1074/jbc.M008072200)
2. Bertin J et al. 1999 Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κB. J. Biol. Chem. 274, 12 955-12 958. (doi:10.1074/jbc.274.19.12955)
3. Hu Z et al. 2013 Crystal structure of NLRC4 reveals its autoinhibition mechanism. Science 341, 172-175. (doi:10.1126/science.1236381)
4. Tanabe T et al. 2004 Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 23, 1587-1597. (doi:10.1038/ sj.emboj.7600175)
5. Hampe J, Franke A, Rosenstiel P, Till A. 2007 A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211. (doi:10.1038/ng1954)
6. Zhernakova A et al. 2008 Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am. J. Hum. Genet. 82, 1202-1210. (doi:10.1016/j.ajhg.2008.03.016)
7. Travassos LH et al. 2010 Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 11, 55-62. (doi:10.1038/ni.1823)
8. Hsu Y-MS, Zhang Y, You Y, Wang D, Li H, Duramad O, Qin X-F, Dong C, Lin X. 2007 The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat. Immunol. 8, 198-205. (doi:10.1038/ni1426)
9. Parkhouse R, Boyle JP, Mayle S, Sawmynaden K, Rittinger K, Monie TP. 2014 Interaction between NOD2 and CARD9 involves the NOD2 NACHT and the linker region between the NOD2 CARDs and NACHT domain. FEBS Lett. 588, 2830-2836. (doi:10.1016/ j.febslet.2014.06.035)
10. Bielig H, Zurek B, Kutsch A, Menning M, Philpott DJ, Sansonetti PJ, Kufer TA. 2009 A function for AAMP in Nod2-mediated NF-kB activation. Mol. Immunol. 46, 2647-2654. (doi:10.1016/j.molimm. 2009.04.022)
11. Ver Heul AM, Fowler CA, Ramaswamy S, Piper RC.2013 Ubiquitin regulates caspase recruitment domain-mediated signaling by nucleotide-binding oligomerization domain-containing proteins NOD1 and NOD2. J. Biol. Chem. 288, 6890-6902. (doi:10. 1074/jbc.M112.413781)
12. Boada-Romero E, Letek M. 2013 TMEM59 defines a novel ATG16L1-binding motif that promotes local activation of LC3. EMBO J. 32, 566-582. (doi:10. 1038/emboj.2013.8)
13. Eitel J et al . 2008 b-PIX and Rac1 GTPase mediate trafficking and negative regulation of NOD2. J. Immunol. 181, 2664-2671. (doi:10.4049/ jimmunol.181.4.2664)
14. Jounai N, Kobiyama K, Shiina M, Ogata K, Ishii KJ, Takeshita F. 2011 NLRP4 negatively regulates autophagic processes through an association with beclin1. J. Immunol. 186, 1646-1655. (doi:10. 4049/jimmunol.1001654)
15. Yeretssian G, Correa RG, Doiron K, Fitzgerald P, Dillon CP, Green DR, Reed JC, Saleh M. 2011 Nonapoptotic role of BID in inflammation and innate immunity. Nature 474, 96-99. (doi:10.1038/ nature09982)
16. Richmond AL et al. 2012 The nucleotide synthesis enzyme CAD inhibits NOD2 antibacterial function in human intestinal epithelial cells. Gastroenterology 142, 1483-1492.e6. (doi:10.1053/j.gastro.2012.02.040)
17. Von Kampen O, Lipinski S, Till A, Martin SJ, Nietfeld W, Lehrach H, Schreiber S, Rosenstiel P. 2010 Caspase recruitment domain-containing protein 8 (CARD8) negatively regulates NOD2-mediated signaling. J. Biol. Chem. 285, 19 921-19 926. (doi:10.1074/jbc.M110.127480)
18. McGovern DPB et al . 2006 TUCAN (CARD8) genetic variants and inflammatory bowel disease. Gastroenterology 131, 1190-1196. (doi:10.1053/j. gastro.2006.08.008)
19. Yoo NJ, Park WS, Kim SY, Reed JC, Son SG, Lee JY, Lee SH. 2002 Nod1, a CARD protein, enhances pro-interleukin-1b processing through the interaction with pro-caspase-1. Biochem. Biophys. Res. Commun. 299, 652-658. (doi:10.1016/S0006-291X(02)02714-6)
20. Hsu L-C et al. 2008 A NOD2-NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl Acad. Sci. USA 105, 7803-7808. (doi:10.1073/pnas.0802726105)
21. Till A, Rosenstiel P, Brä utigam K, Sina C, Jacobs G, Oberg H-H, Seegert D, Chakraborty T, Schreiber S. 2008 A role for membrane-bound CD147 in NOD2-mediated recognition of bacterial cytoinvasion. J. Cell Sci. 121, 487-495. (doi:10.1242/jcs.016980)
22. Yamamoto-Furusho JK, Barnich N, Xavier R, Hisamatsu T, Podolsky DK. 2006 Centaurin b1 down-regulates nucleotide-binding oligomerization domains 1- and 2-dependent NF-κB activation. J. Biol. Chem. 281, 36 060-36 070. (doi:10.1074/ jbc.M602383200)
23. Lipinski S, Till A, Sina C, Arlt A, Grasberger H, Schreiber S, Rosenstiel P. 2009 DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses. J. Cell Sci. 122, 3522-3530. (doi:10.1242/jcs.050690)
24. McDonald C, Chen FF, Ollendorff V, Ogura Y, Marchetto S, Lé cine P, Borg J-P, Nuñ ez G. 2005 A role for Erbin in the regulation of Nod2-dependent NF-kB signaling. J. Biol. Chem. 280, 40 301-40 309. (doi:10.1074/jbc.M508538200)
25. Kufer TA, Kremmer E, Banks DJ, Philpott DJ. 2006 Role for Erbin in bacterial activation of Nod2. Infect. Immun. 74, 3115-3124. (doi:10.1128/IAI. 00035-06)
26. Lipinski S, Grabe N. 2012 RNAi screening identifies mediators of NOD2 signaling: implications for spatial specificity of MDP recognition. Proc. Natl Acad. Sci. USA 109, 21 426-21 431. (doi:10.1073/ pnas.1209673109)
27. Barnich N, Hisamatsu T, Aguirre JE, Xavier R, Reinecker H-C, Podolsky DK. 2005 GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. J. Biol. Chem. 280, 19 021-19 026. (doi:10.1074/jbc. M413776200)
28. Mohanan V, Grimes CL. 2014 The molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn disease. J. Biol. Chem. 289, 18 987-18 998. (doi:10.1074/jbc.M114. 557686)
29. Hahn J-S. 2005 Regulation of Nod1 by Hsp90 chaperone complex. FEBS Lett. 579, 4513-4519. (doi:10.1016/j.febslet.2005.07.024)
30. Mayor A, Martinon F, De Smedt T, Pé trilli V, Tschopp J. 2007 A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nat. Immunol. 8, 497-503. (doi:10.1038/ni1459)
31. Lee K-H, Biswas A, Liu Y-J, Kobayashi KS. 2012 Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components. J. Biol. Chem. 287, 39 800-39 811. (doi:10.1074/jbc. M112.410027)
32. Lecat A et al. 2012 The c-Jun N-terminal kinase (JNK)-binding protein (JNKBP1) acts as a negative regulator of NOD2 protein signaling by inhibiting its oligomerization process. J. Biol. Chem. 287, 29 213-29 226. (doi:10.1074/jbc.M112.355545)
33. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, Xiang Y, Bose S. 2009 Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10, 1073-1080. (doi:10.1038/ ni.1782)
34. Pan Q, Kravchenko V, Katz A, Huang S. 2006 NF-kBinducing kinase regulates selected gene expression in the Nod2 signaling pathway. Infect. Immun. 74, 2121-2127. (doi:10.1128/IAI.74.4.2121)
35. Damiano JS, Oliveira V, Welsh K, Reed JC. 2004 Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses. Biochem. J. 381, 213-219. (doi:10.1042/ BJ20031506)
36. Damiano JS, Stehlik C, Pio F, Godzik A, Reed JC. 2001 CLAN, a novel human CED-4-like gene. Genomics 75, 77-83. (doi:10.1006/geno. 2001.6579)
37. Wagner RN, Proell M, Kufer TA, Schwarzenbacher R. 2009 Evaluation of Nod-like receptor (NLR) effector domain interactions. PLoS ONE 4, e4931. (doi:10. 1371/journal.pone.0004931)
38. Cummings JRF et al. 2010 The genetics of NOD-like receptors in Crohn's disease. Tissue Antigens 76, 48-56. (doi:10.1111/j.1399-0039.2010.01470.x)
39. Dugan JW et al. 2009 Nucleotide oligomerization domain-2 interacts with 2′ -5′ -oligoadenylate synthetase type 2 and enhances RNase-L function in THP-1 cells. Mol. Immunol. 47, 560-566. (doi:10. 1016/j.molimm.2009.09.025)
40. Legrand-Poels S, Kustermans G, Bex F, Kremmer E, Kufer TA, Piette J. 2007 Modulation of Nod2-dependent NF- kB signaling by the actin cytoskeleton. J. Cell Sci. 120, 1299-1310. (doi:10. 1242/jcs.03424)
41. Morosky SA, Zhu J, Mukherjee A, Sarkar SN, Coyne CB. 2011 Retinoic acid-induced gene-I (RIG-I) associates with nucleotide-binding oligomerization domain-2 (NOD2) to negatively regulate inflammatory signaling. J. Biol. Chem. 286, 28 574-28 583. (doi:10.1074/jbc.M111.227942)
42. Park J-H, Kim Y-G, McDonald C, Kanneganti T-D, Hasegawa M, Body-Malapel M, Inohara N, Nunez G. 2007 RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178, 2380-2386. (doi:10.4049/ jimmunol.178.4.2380)
43. Lé cine P et al. 2007 The NOD2-RICK complex signals from the plasma membrane. J. Biol. Chem. 282, 15 197-15 207. (doi:10.1074/jbc.M606242200)
44. Da Silva Correia J, Miranda Y, Leonard N, Ulevitch R. 2007 SGT1 is essential for Nod1 activation. Proc. Natl Acad. Sci. USA 104, 6764-6769. (doi:10.1073/ pnas.0610926104)
45. Nakamura N et al. 2014 Endosomes are specialized platforms for bacterial sensing and NOD2 signalling. Nature 509, 240-244. (doi:10.1038/nature13133)
46. Bielig H et al. 2014 The cofilin phosphatase slingshot homolog 1 (SSH1) links NOD1 signaling to actin remodeling. PLoS Pathog. 10, e1004351. (doi:10.1371/journal.ppat.1004351)
47. Nimmo ER et al. 2011 TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's disease. Gastroenterology 141, 972-981.e2. (doi:10.1053/j. gastro.2011.05.043)
48. Marinis JM, Homer CR, McDonald C, Abbott DW. 2011 A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to downregulate innate immune responses. J. Biol. Chem. 286, 1938-1950. (doi:10.1074/jbc.M110.189308)
49. Zurek B et al. 2012 TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation. PLoS ONE 7, e41255. (doi:10.1371/ journal.pone.0041255)
50. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. 2003 Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872. (doi:10.1074/jbc. C200651200)
51. Vavricka S, Musch M, Chang J, Nakagawa Y, Phanvijhitsiri K, Waypa TS, Merlin D, Schneewind O, Chang EB. 2004 hPepT1 transports muramyl dipeptide, activating NF-κB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. Gastroenterology 127, 1401-1409. (doi:10.1053/j.gastro.2004.07.024)
52. Dalmasso G, Nguyen HTT, Charrier-Hisamuddin L, Yan Y, Laroui H, Demoulin B, Sitaraman SV, Merlin D. 2010 PepT1 mediates transport of the proinflammatory bacterial tripeptide L-Ala-γ-D-Glu-meso-DAP in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G687-G696. (doi:10.1152/ajpgi.00527.2009)
53. Lee J, Tattoli I, Wojtal KA, Vavricka SR, Philpott DJ, Girardin SE. 2009 pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. J. Biol. Chem. 284, 23 818-23 829. (doi:10.1074/jbc.M109.033670)
54. Nigro G et al. 2008 Muramylpeptide shedding modulates cell sensing of Shigella flexneri. Cell. Microbiol. 10, 682-695. (doi:10.1111/j.1462-5822. 2007.01075.x)
55. Kaparakis M et al. 2010 Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell. Microbiol. 12, 372-385. (doi:10.1111/j.1462-5822.2009.01404.x)
56. Bielig H, Rompikuntal PK, Dongre M, Zurek B, Lindmark B, Ramstedt M, Wai SN, Kufer TA. 2011 NOD-like receptor activation by outer membrane vesicles from Vibrio cholerae non-O1 non-O139 strains is modulated by the quorum-sensing regulator HapR. Infect. Immun. 79, 1418-1427. (doi:10.1128/IAI.00754-10)
57. Grimes CL, Ariyananda LDZ, Melnyk JE, O'Shea EK. 2012 The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment. J. Am. Chem. Soc. 134, 13 535-13 537. (doi:10. 1021/ja303883c)
58. Mo J, Boyle JP, Howard CB, Monie TP, Davis BK, Duncan JA. 2012 Pathogen sensing by nucleotidebinding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP. J. Biol. Chem. 287, 23 057-23 067. (doi:10.1074/jbc.M112.344283)
59. Girardin SE, Jé hanno M, Mengin-Lecreulx D, Sansonetti PJ, Alzari PM, Philpott DJ. 2005 Identification of the critical residues involved in peptidoglycan detection by Nod1. J. Biol. Chem. 280, 38 648-38 656. (doi:10.1074/jbc. M509537200)
60. Boyle JP, Mayle S, Parkhouse R, Monie TP. 2013 Comparative genomic and sequence analysis provides insight into the molecular functionality of NOD1 and NOD2. Front. Immunol. 4, 317. (doi:10. 3389/fimmu.2013.00317)
61. Miceli-Richard C et al. 2001 CARD15 mutations in Blau syndrome. Nat. Genet. 29, 19-20. (doi:10. 1038/ng720)
62. Parkhouse R, Boyle JP, Monie TP. 2014 Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators. FEBS Lett. 588, 3382-3389. (doi:10.1016/j.febslet.2014.07.029)
63. Magalhaes JG, Lee J, Geddes K, Rubino S, Philpott DJ, Girardin SE. 2011 Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands. Eur. J. Immunol. 41, 1445-1455. (doi:10.1002/eji. 201040827)
64. Girardin SE et al. 2001 CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2, 736-742. (doi:10.1093/ embo-reports/kve155)
65. Windheim M, Lang C, Peggie M, Plater LA, Cohen P. 2007 Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem. J. 404, 179-190. (doi:10.1042/ BJ20061704)
66. Rosenstiel P et al. 2006 A short isoform of NOD2h/ CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways. Proc. Natl Acad. Sci. USA 103, 3280-3285. (doi:10.1073/pnas.0505423103)
67. Mayle S, Boyle JP, Sekine E, Zurek B, Kufer TA, Monie TP. 2014 Engagement of nucleotide-binding oligomerization domain-containing protein 1 (NOD1) by receptor-interacting protein 2 (RIP2) is insufficient for signal transduction. J. Biol. Chem. 289, 22 900-22 914. (doi:10.1074/jbc.M114. 557900)
68. Fridh V, Rittinger K. 2012 The tandem CARDs of NOD2: intramolecular interactions and recognition of RIP2. PLoS ONE 7, e34375. (doi:10.1371/journal. pone.0034375)
69. Coussens NP, Mowers JC, McDonald C, Nuñ ez G, Ramaswamy S. 2007 Crystal structure of the Nod1 caspase activation and recruitment domain. Biochem. Biophys. Res. Commun. 353, 1-5. (doi:10. 1016/j.bbrc.2006.11.122)
70. Manon F, Favier A, Nú ñ ez G, Simorre J-P, Cusack S. 2007 Solution structure of NOD1 CARD and mutational analysis of its interaction with the CARD of downstream kinase RICK. J. Mol. Biol. 365, 160-174. (doi:10.1016/j.jmb.2006.09.067)
71. Srimathi T, Robbins SL, Dubas RL, Hasegawa M, Inohara N, Park YC. 2008 Monomer/dimer transition of the caspase-recruitment domain of human Nod1. Downloaded from Biochemistry 47, 1319-1325. (doi:10.1021/ bi7016602)
72. Ver Heul AM, Gakhar L, Piper RC, Subramanian R. 2014 Crystal structure of a complex of NOD1 CARD and ubiquitin. PLoS ONE 9, e104017. (doi:10.1371/ journal.pone.0104017)
73. Nam Y-J, Mani K, Ashton AW, Peng C-F, Krishnamurthy B, Hayakawa Y, Lee P, Korsmeyer SJ, Kitsis RN. 2004 Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Mol. Cell 15, 901-912. (doi:10.1016/j.molcel.2004.08.020)
74. Koseki T, Inohara N, Chen S, Carrio R, Merino J, Hottiger MO, Nabel GJ, Nunez G. 1999 CIPER, a novel NF-κB-activating protein containing a caspase recruitment domain with homology to herpes virus-2 protein E10. J. Biol. Chem. 274, 9955-9961. (doi:10.1074/jbc.274.15.9955)
75. Oppermann FS, Gnad F, Olsen JV, Hornberger R, Greff Z, Ké ri G, Mann M, Daub H. 2009 Large-scale proteomics analysis of the human kinome. Mol. Cell. Proteomics 8, 1751-1764. (doi:10.1074/mcp. M800588-MCP200)
76. Dorsch M et al. 2006 Identification of a regulatory autophosphorylation site in the serine-threonine kinase RIP2. Cell. Signal. 18, 2223-2229. (doi:10. 1016/j.cellsig.2006.05.005)
77. Daub H et al. 2008 Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol. Cell 31, 438-448. (doi:10.1016/j.molcel.2008.07.007)
78. Zhao Y, Alonso C, Ballester I. 2012 Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1. Inflamm. Bowel Dis. 18, 603-612. (doi:10. 1002/ibd.21851.Control)
79. Tigno-Aranjuez J. 2010 Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses. Genes Dev. 24, 2666-2677. (doi:10. 1101/gad.1964410)
80. Olsen JV et al. 2010 Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. 3, ra3. (doi:10.1126/scisignal. 2000475)
81. Dephoure N, Zhou C, Villé n J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP. 2008 A quantitative atlas of mitotic phosphorylation. Proc. Natl Acad. Sci. USA 105, 10 762-10 767. (doi:10. 1073/pnas.0805139105)
82. Hara H et al. 2013 Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity. Nat. Immunol. 14, 1247-1255. (doi:10.1038/ni.2749)
83. Tao M, Scacheri PC, Marinis JM, Harhaj EW, Matesic LE, Abbott DW. 2009 ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways. Curr. Biol. 19, 1255-1263. (doi:10.1016/j.cub.2009.06.038)
84. Bertrand MJM, Doiron K, Labbé K, Korneluk RG, Barker PA, Saleh M. 2009 Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 30, 789-801. (doi:10.1016/j.immuni.2009.04.011)
85. Krieg A, Correa RG, Garrison JB, Le Negrate G, Welsh K, Huang Z, Knoefel WT, Reed JC. 2009 XIAP mediates NOD signaling via interaction with RIP2. Proc. Natl Acad. Sci. USA 106, 14 524-14 529. (doi:10.1073/pnas.0907131106)
86. Damgaard RB et al. 2012 The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol. Cell 46, 746-758. (doi:10.1016/j.molcel.2012.04.014)
87. Yang S et al. 2013 Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis. Nat. Immunol. 14, 927-936. (doi:10.1038/ni.2669)
88. Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, Nú ñ ez G, Inohara N. 2008 A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kB activation. EMBO J. 27, 373-383. (doi:10.1038/sj. emboj.7601962)
89. Clark NM, Marinis JM, Cobb BA, Abbott DW. 2008 MEKK4 sequesters RIP2 to dictate NOD2 signal specificity. Curr. Biol. 18, 1402-1408. (doi:10.1016/ j.cub.2008.07.084)
90. Inohara N, Koseki T, Lin J, del Peso L, Lucas PC, Chen FF, Ogura Y, Nú ñ ez G. 2000 An induced proximity model for NF-k B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275, 27 823-27 831. (doi:10. 1074/jbc.M003415200)
91. Levine B, Mizushima N, Virgin HW. 2011 Autophagy in immunity and inflammation. Nature 469, 323-335. (doi:10.1038/nature09782)
92. Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y. 2009 Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat. Rev. Mol. Cell Biol. 10, 458-467. (doi:10.1038/nrm2708)
93. Jounai N, Takeshita F. 2007 The Atg5-Atg12 conjugate associates with innate antiviral immune responses. Proc. Natl Acad. Sci. USA 104, 14 050-14 055. (doi:10.1073/pnas.0704014104)
94. Cooney R et al. 2010 NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 16, 90-97. (doi:10.1038/nm.2069)
95. Fujita N, Itoh T, Omori H. 2008 The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol. Biol. Cell 19, 2092-2100. (doi:10.1091/mbc.E07)
96. Mizushima N, Kuma A, Kobayashi Y, Yamamato A, Matsubae M, Takao T, Natsume T, Ohsumi Y, Yoshimori T. 2003 Mouse Apg16L, a novel WDrepeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J. Cell Sci. 116, 1679-1688. (doi:10.1242/jcs.00381)
97. Anand P, Tait S, Lamkanfi M. 2011 TLR2 and RIP2 pathways mediate autophagy of Listeria monocytogenes via extracellular signal-regulated kinase (ERK) activation. J. Biol. Chem. 286, 42 981-42 991. (doi:10.1074/jbc.M111.310599)
98. Homer CR, Kabi A, Marina-García N, Sreekumar A, Nesvizhskii AI, Nickerson KP, Chinnaiyan AM, Nuñ ez G, McDonald C. 2012 A dual role for receptorinteracting protein kinase 2 (RIP2) kinase activity in 11 rsob.royalsocietypublishing.org Open Biol. 4: 140178 27, 2015 nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy. J. Biol. Chem. 287, 25 565-25 576. (doi:10.1074/jbc.M111.326835)
99. Homer C, Richmond A, Rebert N. 2010 ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 139, 1630-1641. (doi:10.1053/j.gastro.2010.07.006)
100. Barnich N, Aguirre JE, Reinecker H-C, Xavier R, Podolsky DK. 2005 Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factorkB activation in muramyl dipeptide recognition. J. Cell Biol. 170, 21-26. (doi:10.1083/jcb.200502153)
101. Irving AT et al. 2014 The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling. Cell Host Downloaded from Microbe 15, 623-635. (doi:10.1016/j.chom.2014. 04.001)
102. Kufer TA, Kremmer E, Adam AC, Philpott DJ, Sansonetti PJ. 2008 The pattern-recognition molecule Nod1 is localized at the plasma membrane at sites of bacterial interaction. Cell. Microbiol. 10, 477-486. (doi:10.1111/j.1462-5822. 2007.01062.x)
103. Keestra AM et al. 2013 Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1. Nature 496, 233-237. (doi:10.1038/ nature12025)
104. Keestra AM, Winter MG, Klein-Douwel D, Xavier MN, Winter SE, Kim A, Tsolis RM, Bá umler AJ. 2011 A Salmonella virulence factor activates the NOD1/ NOD2 signaling pathway. MBio 2, e00266-11. (doi:10.1128/mBio.00266-11)
105. Hall A. 1998 Rho GTPases and the actin cytoskeleton. Science 279, 509-514. (doi:10.1126/ science.279.5350.509)
106. Bustelo X, Sauzeau V, Berenjeno I. 2007 GTPbinding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 29, 356-370. (doi:10.1002/bies.20558)
107. Shi J, Scita G, Casanova JE. 2005 WAVE2 signaling mediates invasion of polarized epithelial cells by Salmonella typhimurium. J. Biol. Chem. 280, 29 849-29 855. (doi:10.1074/jbc. M500617200)
108. Stenzel N, Fetzer CP, Heumann R, Erdmann KS. 2009 PDZ-domain-directed basolateral targeting of the peripheral membrane protein FRMPD2 in epithelial cells. J. Cell Sci. 122, 3374-3384. (doi:10. 1242/jcs.046854)